Descuento:
-5%Antes:
Despues:
153,14 €1. Definition and Epidemiology of COPD
2. Risk Factors: Factors That Influence Disease Development and Progression
3. Pathology of Chronic Obstructive Pulmonary Diseases
4. Pathogenesis of COPD
5. Pathophysiology of COPD
6. Diagnosis and Assessment of COPD
7. Symptomatic Assessment of COPD
8. Imaging of COPD
9. Biomarkers of COPD
10. Phenotypes of COPD
11. Genetics of COPD
12. Imaging Heterogeneity of COPD
13. Asthma-COPD Overlap Syndrome
14. The Spectrum of Pulmonary Disease in COPD
15. Prevention of COPD
16. Pharmacologic Management
17. Non-pharmacologic Management: LVR, Rehabilitation, and Nutrition
18. Exacerbation of COPD
19. Comorbidities: Assessment and Treatment
20. Personalized Treatment in COPD
21. Cohort Study in COPD: Introduction to COPD Cohorts (The KOLD and COPDGene Study) and Collaborative Approaches
22. Big Data and Network Medicine in COPD
This book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.). Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous illustrations. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset in clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.
Features
• Explains how analysis of the heterogeneity of COPD leads to improved, personalized treatment
• Presents state of the art knowledge on a range of issues related to COPD heterogeneity
• Describes an appropriate tailored treatment strategy for each subgroup of patients
Authors
Sang-Do Lee is Professor in Pulmonary and Critical Care Medicine at University of Ulsan College of Medicine. He is the President of Asan Medical Center, Seoul and Director at Clinical Research Center for Chronic Obstructive Airway Diseases.
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
